Molecure SA
WSE:MOC
Income Statement
Earnings Waterfall
Molecure SA
Income Statement
Molecure SA
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
2
+67%
|
2
+0%
|
2
+2%
|
2
-19%
|
2
0%
|
1
-15%
|
1
+1%
|
4
+165%
|
0
-90%
|
0
-1%
|
1
+101%
|
2
+205%
|
5
+153%
|
5
-7%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
|
| Gross Profit |
1
N/A
|
2
+73%
|
2
-3%
|
1
-21%
|
1
-60%
|
0
-74%
|
(1)
N/A
|
(0)
+16%
|
(0)
-6%
|
(2)
-256%
|
(2)
-21%
|
(2)
-1%
|
(1)
+36%
|
3
N/A
|
3
-1%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(12)
|
(16)
|
(18)
|
(19)
|
(17)
|
(18)
|
(19)
|
(21)
|
(32)
|
(23)
|
(25)
|
(27)
|
(31)
|
(29)
|
(28)
|
|
| Selling, General & Administrative |
(5)
|
(6)
|
(7)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(17)
|
(13)
|
(14)
|
(15)
|
(19)
|
(19)
|
(19)
|
|
| Research & Development |
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(3)
|
|
| Other Operating Expenses |
(4)
|
(8)
|
(9)
|
(9)
|
(7)
|
(8)
|
(8)
|
(9)
|
(11)
|
(8)
|
(8)
|
(8)
|
(8)
|
(6)
|
(6)
|
|
| Operating Income |
(11)
N/A
|
(15)
-31%
|
(16)
-10%
|
(17)
-7%
|
(17)
+3%
|
(18)
-7%
|
(19)
-8%
|
(22)
-11%
|
(32)
-49%
|
(25)
+23%
|
(27)
-9%
|
(29)
-5%
|
(32)
-13%
|
(26)
+18%
|
(25)
+4%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
2
|
3
|
4
|
4
|
4
|
3
|
1
|
2
|
1
|
1
|
1
|
|
| Non-Reccuring Items |
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
0
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(14)
N/A
|
(15)
-8%
|
(16)
-7%
|
(16)
-3%
|
(15)
+5%
|
(15)
+0%
|
(16)
-2%
|
(17)
-12%
|
(28)
-63%
|
(22)
+23%
|
(26)
-16%
|
(28)
-8%
|
(31)
-13%
|
(25)
+19%
|
(24)
+4%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(14)
|
(15)
|
(16)
|
(16)
|
(15)
|
(15)
|
(16)
|
(17)
|
(28)
|
(22)
|
(26)
|
(28)
|
(31)
|
(25)
|
(24)
|
|
| Net Income (Common) |
(14)
N/A
|
(15)
-8%
|
(16)
-7%
|
(16)
-3%
|
(15)
+5%
|
(15)
+0%
|
(16)
-2%
|
(17)
-12%
|
(28)
-63%
|
(22)
+23%
|
(26)
-16%
|
(28)
-8%
|
(31)
-13%
|
(25)
+19%
|
(24)
+4%
|
|
| EPS (Diluted) |
-0.98
N/A
|
-1.06
-8%
|
-1.13
-7%
|
-1.15
-2%
|
-1.09
+5%
|
-1.09
N/A
|
-1.11
-2%
|
-1.03
+7%
|
-1.69
-64%
|
-1.28
+24%
|
-1.52
-19%
|
-1.64
-8%
|
-1.55
+5%
|
-1.23
+21%
|
-1.2
+2%
|
|